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Objective
To investigate the diagnostic value and clinical signifi-
cance of anti-MCV in pts with early JA.
Patients and methods: 85 pts were included in the study
(M/F = 36/49) in the age of 1,5–16 years (mean 8.7 ± 4.9
years). Systemic JA – 10 pts (11.8%), poly – 37 (43.5%),
oligo-38 (44.7%). Duration of disease was < 6 months.
We studied also 54 pts with early RA, 28 pts with undiffer-
entiated arthritis (UA) and 14 healthy children. Anti-MCV
was measured in serum by enzyme-linked immunosorb-
ent assay (ELISA) using the cut off value of 25 U/ml. IgM
RF and hsCRP-by laser-nephelometry assay on BN-100
analyser.
Results
Anti-MCV levels were elevated in 23 (27.1%) pts with
early JA, in systemic – 2 (20%), poly – 11(29.7%), oligo-
10 (26.3%). In pts with RF positive JA – 5 (100%), in RF
negative pts- 7(17.1%) (p < 0.001). In the control groups:
34/54 (62.9%) adults with early RA (p < 0,001), 14/28
(50%) with UA (p < 0.05), none of the healthy children
showed anti-MCV positivity. The median anti-MCV level
in JA was 16.8 U/ml (IR: 11.5–26.4), in RF+ pts (M-834.9;
IR 539.3–1149.3 U/ml) was higher than in RF-pts (M-
14.5; IR:5.7–22.0 U/ml) (p < 0.001). Anti-MCV correlated
with parameters of disease activity (hs CRP, ESR), with RF
and anti-CCP positivity. Anti-MCV were not associated
with ANA.
Conclusion
Determination of anti-MCV levels especially together with
RF and anti-CCP in pts with early JA can indicate evolu-
tion JRA similar RA in adults. Anti-MCV levels correlated
with common parameters of inflammation and acute
phase response and may be useful to monitor disease
activity.
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